EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring

Ga Young Moon, Basak Dalkiran iD, Hyun Sung Park, Dongjun Shin iD, Chaeyeon Son, Jung Hyun Choi, Seha Bang, Hosu Lee, Il Doh, Dong Hyung Kim, Woo-Jin Jeong iD, Jiyoon Bu

Biosensors · 2025

DOI: 10.3390/bios15020074 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Ga Young Moon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Circulating Tumor DNA, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liquid biopsy has gained significant attention in cancer diagnostics, with circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) being recognized as key biomarkers for tumor detection and monitoring. However, each biomarker possesses inherent limitations that restrict its standalone clinical utility, such as the rarity and heterogeneity of CTCs and the variable sensitivity and specificity of ctDNA assays. This highlights the necessity of integrating both biomarkers to maximize diagnostic and prognostic potential, offering a more comprehensive understanding of the tumor biology and therapeutic response. In this review, we summarize clinical studies that have explored the combined analysis of CTCs and ctDNA as biomarkers, providing insights into their synergistic value in diverse tumor types. Specifically, this paper examines the individual advantages and limitations of CTCs and ctDNA, details the findings of combined biomarker studies across various cancers, highlights the benefits of dual biomarker approaches over single-biomarker strategies, and discusses future prospects for advancing personalized oncology through liquid biopsies. By offering a comprehensive overview of clinical studies combining CTCs and ctDNA, this review serves as a guideline for researchers and clinicians aiming to enhance biomarker-based strategies in oncology and informs biosensor design for improved biomarker detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingCirculating Tumor DNABiomarkers, TumorNeoplasmsHumansLiquid BiopsyBiosensing Techniques

Stichwörter der Autor:innen

circulating tumor DNA (ctDNA)circulating tumor cells (CTCs)diagnostic biomarkerliquid biopsytumor diagnosis

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea.
  • Division of Biomedical Metrology, Korea Research Institute of Standards and Science, 267 Gajeongno, Yuseong-gu, Daejeon 34113, Republic of Korea.
  • Department of Biological Engineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea.
  • Biohybrid Systems Research Center, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea.

ORCID-Profile: Basak Dalkiran, Dongjun Shin, Woo-Jin Jeong

Förderung

  • National Research Foundation of Korea
  • Korean Fund for Regenerative Medicine
  • Korea Health Industry Development Institute
  • National Research Council of Science & Technology
  • Inha University
  • National Research Council of Science & Technology

Zitieren

APA

Moon, G. Y., Dalkiran, B., Park, H. S., Shin, D., Son, C., Choi, J. H., Bang, S., Lee, H., Doh, I., Kim, D. H., Jeong, W. J., & Bu, J. (2025). Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring. Biosensors. https://doi.org/10.3390/bios15020074

Vancouver

Moon GY, Dalkiran B, Park HS, Shin D, Son C, Choi JH, et al. Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring. Biosensors. 2025. doi:10.3390/bios15020074

BibTeX
@article{Moon2025,
  author = {Moon, Ga Young and Dalkiran, Basak and Park, Hyun Sung and Shin, Dongjun and Son, Chaeyeon and Choi, Jung Hyun and Bang, Seha and Lee, Hosu and Doh, Il and Kim, Dong Hyung and Jeong, Woo-Jin and Bu, Jiyoon},
  title = {Dual Biomarker Strategies for Liquid Biopsy: Integrating Circulating Tumor Cells and Circulating Tumor DNA for Enhanced Tumor Monitoring},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15020074}
}
Kostenlos starten →